Performance Assessment of Sysmex® CA-104 for Screening Coagulogram Testing

Authors

  • Chaicharoen Tantanate Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700

Abstract

Objective: The Sysmex® CA-104 (CA-104) is a new, semi-automated coagulation analyzer which has not yet been evaluated in Thailand. The objective of this study was to evaluate the CA-104 performance for prothrombin time (PT), activated partial thromboplastin time (APTT), and international normalized ratio (INR) under local laboratory conditions.
Methods: Real patient samples and control materials were used to evaluate CA-104 in terms of precision, reference range, and comparability to the validated Sysmex® CS-2100i analyzer (CS-2100i).
Results: The highest percentages of coefficient of variation of PT and APTT were 1.34 and 1.47 for within-run, and 3.2 and 1.65 for between-run precision studies. Correlation coefficients of PT, APTT, and INR between CA-104 and CS-2100i were 0.97, 0.95, and 0.99, respectively. Mean biases of PT, APTT, and INR of CA-104 compared with those from CS-2100i were low. Most results were within 95% agreement, although a few values at the high levels were not. For INR testing, no specimen required warfarin dose adjustment when using CA-104 instead of CS-2100i.
Conclusion: Performance of CA-104 for screening coagulogram in terms of precision and comparability to CS-2100i was acceptable. However, a few discrepancies in clotting time at high values were observed. Further investigation to identify the cause of this discrepancy is warranted.

Keywords: Sysmex® CA-104, automated analyzer, performance assessment, screening coagulogram

Downloads

Published

09-03-2016

How to Cite

Tantanate, C. (2016). Performance Assessment of Sysmex® CA-104 for Screening Coagulogram Testing. Siriraj Medical Journal, 68(1), 1–5. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/55199

Issue

Vol. 68 No. 1 (2016): January-February

Section

Original Article

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.